Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survival

[1]  H. Pass,et al.  Differential N-Glycosylation Patterns in Lung Adenocarcinoma Tissue. , 2015, Journal of proteome research.

[2]  Harry J M Groen,et al.  The value of proteomics in lung cancer. , 2015, Annals of translational medicine.

[3]  Oliver Fiehn,et al.  Metabolomic Markers of Altered Nucleotide Metabolism in Early Stage Adenocarcinoma , 2015, Cancer Prevention Research.

[4]  T. G. Grunewald,et al.  An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein , 2014, Oncotarget.

[5]  Danielle G. Lemay,et al.  The Human Colostrum Whey Proteome Is Altered in Gestational Diabetes Mellitus , 2014, Journal of proteome research.

[6]  Naveed Hasan,et al.  Lung Cancer Screening Beyond Low-Dose Computed Tomography: The Role of Novel Biomarkers , 2014, Lung.

[7]  S. Liang,et al.  LASP-1 promotes tumor proliferation and metastasis and is an independent unfavorable prognostic factor in gastric cancer , 2014, Journal of Cancer Research and Clinical Oncology.

[8]  Jeffrey R. Whiteaker,et al.  Proteogenomic characterization of human colon and rectal cancer , 2014, Nature.

[9]  H. J. Kim,et al.  Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas , 2014, British Journal of Cancer.

[10]  Thomas D. Wu,et al.  Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer , 2014, Nature Communications.

[11]  S. Pedersen,et al.  Regulation and roles of bicarbonate transporters in cancer , 2014, Front. Physiol..

[12]  Andrew R. Jones,et al.  ProteomeXchange provides globally co-ordinated proteomics data submission and dissemination , 2014, Nature Biotechnology.

[13]  G. Kroemer,et al.  The protein disulfide isomerases PDIA4 and PDIA6 mediate resistance to cisplatin-induced cell death in lung adenocarcinoma , 2014, Cell Death and Differentiation.

[14]  K. O'Byrne,et al.  Prognostic impact of vascular and lymphovascular invasion in early lung cancer , 2014, Asian cardiovascular & thoracic annals.

[15]  Paul Kearney,et al.  A Blood-Based Proteomic Classifier for the Molecular Characterization of Pulmonary Nodules , 2013, Science Translational Medicine.

[16]  D. Lin,et al.  Proteomics-based identification of tumor relevant proteins in lung adenocarcinoma. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[17]  Robert V Farese,et al.  Cellular fatty acid metabolism and cancer. , 2013, Cell metabolism.

[18]  Liang Zhao,et al.  LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma. , 2013, European journal of cancer.

[19]  David E. Muench,et al.  c-Myc and Cancer Metabolism , 2012, Clinical Cancer Research.

[20]  E. Morii,et al.  Role of leucine-rich pentatricopeptide repeat motif-containing protein (LRPPRC) for anti-apoptosis and tumourigenesis in cancers. , 2012, European journal of cancer.

[21]  P. Massion,et al.  In-depth Proteomic Analysis of Nonsmall Cell Lung Cancer to Discover Molecular Targets and Candidate Biomarkers* , 2012, Molecular & Cellular Proteomics.

[22]  M. Berry,et al.  Lymphovascular Invasion in Non–Small-Cell Lung Cancer: Implications for Staging and Adjuvant Therapy , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[23]  F. Laurindo,et al.  Protein disulfide isomerase in redox cell signaling and homeostasis. , 2012, Free radical biology & medicine.

[24]  Libing Song,et al.  Knockdown of stomatin‐like protein 2 (STOML2) reduces the invasive ability of glioma cells through inhibition of the NF‐κB/MMP‐9 pathway , 2012, The Journal of pathology.

[25]  Mark S. Sundrud,et al.  Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase , 2011, Nature chemical biology.

[26]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[27]  Vann Bennett,et al.  Membrane domains based on ankyrin and spectrin associated with cell-cell interactions. , 2009, Cold Spring Harbor perspectives in biology.

[28]  Noel Southall,et al.  COPI Complex Is a Regulator of Lipid Homeostasis , 2008, PLoS biology.

[29]  N. Segarra,et al.  Angiogenesis inhibitors in the treatment of non-small-cell lung cancer (NSCLC). , 2008 .

[30]  B. Jeon,et al.  Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systems. , 2008, Lung cancer.

[31]  K. Bhakat,et al.  Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage , 2008, Nucleic acids research.

[32]  Irina Kusmartseva,et al.  Panel of serum biomarkers for the diagnosis of lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  A. Stojadinovic,et al.  HYOU1/Orp150 expression in breast cancer. , 2007, Medical science monitor : international medical journal of experimental and clinical research.

[34]  Jiandie D. Lin,et al.  Defects in energy homeostasis in Leigh syndrome French Canadian variant through PGC-1alpha/LRP130 complex. , 2006, Genes & development.

[35]  D. Rimm,et al.  X-Tile , 2004, Clinical Cancer Research.

[36]  J. Martinou,et al.  Role of mitochondrial membrane permeabilization in apoptosis and cancer , 2004, Oncogene.

[37]  M. Perry,et al.  Classical Chemotherapy: Mechanisms, Toxicities and the Therapeutc Window , 2003, Cancer biology & therapy.

[38]  Sharon L R Kardia,et al.  Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[39]  B. Freidlin,et al.  Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  J. Chen,et al.  LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancer. , 2015, Cancer research.

[41]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[42]  S. Madhusudan,et al.  Base excision repair factors are promising prognostic and predictive markers in cancer. , 2012, Current molecular pharmacology.

[43]  Satoru Miyano,et al.  Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. , 2012, Cancer research.

[44]  T. Barrette,et al.  ONCOMINE: a cancer microarray database and integrated data-mining platform. , 2004, Neoplasia.

[45]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[46]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.